Also, in curing anaemia of renal origin, EPO given intravenously had positive effects on macular oedema, improved visual acuity in patients with DR and also led to the reduction of exudative maculopathy and proliferative changes of the disease [28, 29]. The gene discussed is EPO; the disease is anemia (phenotype).